Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Extending Long-Term Upside Potential
Revolution Medicines, Inc. ($RVMD) announced an update on their ongoing clinical study. Study Overview Revolution Medicines, Inc. is...
1d ago
RVMD
Daiichi Sankyo’s Next Lung Cancer Bet: What the New Merck Partnership Study Means for Investors
Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Study OverviewThis study, officially titled “KEYMAKER-U01...
1d ago
DSKYF
Boston Scientific’s Global Pulsed Field Ablation Trial Targets Persistent Atrial Fibrillation Growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially...
1d ago
BSX
Novo Nordisk Expands Cardiovascular Ambitions With New Phase 3 Ziltivekimab Plaque Study
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is running a...
1d ago
NVO
Pfizer’s Protonix Pediatric Study Completion: What Investors Should Watch Next
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a...
1d ago
PFE
BeOne Medicines Advances Early Cancer Trial for BG-75098, Signaling Steady Pipeline Progress
BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines is running an early-stage trial...
2d ago
ONC
Daiichi Sankyo’s ADC Push in Gastroesophageal Cancer: What Substudy 06D Means for Investors
Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Study Overview: Substudy 06D, formally titled...
2d ago
DSKYF
MapLight’s Phase 2 Alzheimer’s Psychosis Trial Marks a Key Milestone for MPLT Investors
MapLight Therapeutics, Inc. ($MPLT) announced an update on their ongoing clinical study. MapLight Therapeutics Advances Mid-Stage Trial for...
2d ago
MPLT
AbbVie Targets Dry Eye Market With New ABBV-444 Trial: What Investors Should Watch
Abbvie ($ABBV) announced an update on their ongoing clinical study. Study OverviewAbbVie is running a phase 3 trial...
2d ago
ABBV
Ascentage Pharma Advances Olverembatinib With New Liver Function Study, Offering Gradual Upside for Investors
Ascentage Pharma Group International ($HK:6855) announced an update on their ongoing clinical study. Study Overview The trial, officially...
2d ago
6855
Organogenesis Nears Key Data Milestone With Phase 3 Knee Osteoarthritis Study
Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring...
2d ago
ORGO
Astellas Completes Key Menopause Drug Study in Japan, Setting Up Next Growth Phase for Fezolinetant
Astellas Pharma ($ALPMF) announced an update on their ongoing clinical study. Study Overview Astellas Pharma is running a...
2d ago
ALPMF
AstraZeneca Targets Chemo-Ineligible Lung Cancer Patients With New Osimertinib Trial
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview – AstraZeneca is launching a phase...
3d ago
AZN
AstraZeneca Moves CAR-T Into Autoimmune Diseases, Adding Long-Term Upside to AZN’s Pipeline
AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca Explores CAR-T for Autoimmune Diseases: Early Study...
3d ago
AZN
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest clinical move targets a niche...
3d ago
AMGN
MapLight’s ML-004 Autism Extension Study: What Ongoing Safety Data Mean for Investors
MapLight Therapeutics, Inc. ($MPLT) announced an update on their ongoing clinical study. Study OverviewMapLight Therapeutics is running an...
3d ago
MPLT
Edwards Lifesciences Advances Smart Surgery Monitoring With Completed SMART TRENDS Study
Edwards Lifesciences Corp. ($EW) announced an update on their ongoing clinical study. Study OverviewThe “SMART TRENDS Study,” officially...
3d ago
EW
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Extends Pediatric Psoriasis Study: What Investors...
3d ago
AMGN
Pacira Ends Hip Osteoarthritis Injection Study for ZILRETTA: What Investors Should Know
Pacira ($PCRX) announced an update on their ongoing clinical study. Study Overview: Pacira Pharmaceuticals is running a Phase...
3d ago
PCRX
NeOnc’s NEO100 Brain Tumor Trial Progresses, Keeping a Key Catalyst in Play for Investors
NeOnc Technologies Holdings, Inc. ($NTHI) announced an update on their ongoing clinical study. Study OverviewNeOnc Technologies Holdings, Inc....
6d ago
NTHI
Kaken’s KP-001 Phase 3 Trial Targets Rare Vascular Disorders, Adding Long-Term Upside to KKPCF
Kaken Pharmaceutical Co ($KKPCF) announced an update on their ongoing clinical study. Study Overview: Kaken Pharmaceutical has launched...
6d ago
KKPCF
MoonLake Extends Sonelokimab Data in Psoriatic Arthritis: What Investors Should Watch
Moonlake Immunotherapeutics ($MLTX) announced an update on their ongoing clinical study. Study Overview MoonLake Immunotherapeutics (MLTX) is running...
6d ago
MLTX
Exelixis and Merck Advance LITESPARK-033: A New Kidney Cancer Combo With High-Stakes Market Potential
Exelixis ($EXEL) announced an update on their ongoing clinical study. Study Overview The LITESPARK-033 study, formally titled “A...
6d ago
EXEL
NeOnc’s NEO212 Brain Cancer Trial Progresses: What Investors Should Watch Now
NeOnc Technologies Holdings, Inc. ($NTHI) announced an update on their ongoing clinical study. Study Overview: NeOnc Technologies Holdings,...
6d ago
NTHI
Amgen Advances Olpasiran Heart Plaque Study, Highlighting a Growing Bet on Lipoprotein(a)
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Study Overview Amgen is launching a Phase...
6d ago
AMGN
New Pumitamig Kidney Cancer Trial Adds Long-Term Optionality for Bristol-Myers Squibb and BioNTech
Biontech Se Sponsored Adr ($BNTX), Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol...
6d ago
BMY
BNTX
Bayer Backs AskBio Gene Therapy Push in Pompe Disease: Early Trial Update and Investor Takeaways
Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Study Overview The PROGRESS-GT LOPD trial is...
6d ago
BAYRY
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
SCYNEXIS Inc ($SCYX) announced an update on their ongoing clinical study. Study Overview: SCYNEXIS Inc. (SCYX) is running...
6d ago
SCYX
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
Alpha Tau Medical Ltd ($DRTS) announced an update on their ongoing clinical study. Study Overview – Alpha Tau...
7d ago
DRTS
Sanofi Expands Real‑World Atopic Dermatitis Data With Global Long‑Term Registry
Sanofi SA ($SNY) announced an update on their ongoing clinical study. Study Overview: Sanofi is running a global...
7d ago
SNY
Incyte Steps Into Late-Stage Colorectal Cancer Race With New Phase 3 Trial of INCA33890
Incyte ($INCY) announced an update on their ongoing clinical study. Study Overview Incyte’s new Phase 3 trial, titled...
7d ago
INCY
TROPION-Lung17: New Phase III Lung Cancer Trial Adds Medium-Term Upside Potential for AstraZeneca and Daiichi Sankyo
Daiichi Sankyo Company ($DSKYF), AstraZeneca ($AZN) announced an update on their ongoing clinical study. TROPION-Lung17 Clinical Update: What...
7d ago
AZN
BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206
Biontech Se Sponsored Adr ($BNTX), Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study...
7d ago
BMY
BNTX
AstraZeneca Targets Costly C. Diff Recurrence With New Antibody Trial
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study OverviewAstraZeneca is running a Phase IIb study...
7d ago
AZN
Insulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market
Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview: Insulet Corporation is running a new...
7d ago
PODD
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson’s Disease
Annovis Bio Inc ($ANVS) announced an update on their ongoing clinical study. Study Overview Annovis Bio Inc. is...
7d ago
ANVS
AstraZeneca’s AZD1163 Trial Adds Quiet Option Value in Rheumatoid Arthritis
AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca Advances Mid-Stage Rheumatoid Arthritis Trial With AZD1163...
7d ago
AZN
Pfizer’s New Liver Cancer Trial Signals a Longer-Term Oncology Upside for PFE
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. PFE’s New Liver Cancer Trial: Early Signal...
7d ago
PFE
ORKA-001 Psoriasis Trial: Fresh Phase 2 Update and What It Means for Investors
Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. Study Overview Oruka Therapeutics, Inc. is...
7d ago
ORKA
Eli Lilly Advances Eloralintide Into Phase 3, Reinforcing Its Obesity and Diabetes Pipeline
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
7d ago
LLY
Insulet’s Omnipod SmartAdjust 2.0 Trial Wraps Up: What Investors Should Watch Next
Insulet ($PODD) announced an update on their ongoing clinical study. Study Overview Insulet’s new study, officially titled “Safety...
7d ago
PODD
Shuttle Pharmaceuticals’ Terminated Glioblastoma Trial: What Investors Need to Know Now
Shuttle Pharmaceuticals Holdings, Inc. ($SHPH) announced an update on their ongoing clinical study. Study OverviewShuttle Pharmaceuticals Holdings, Inc....
7d ago
SHPH
AstraZeneca’s AZD5004 Obesity Trial Edges Forward, Raising New Questions for Investors
AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase IIb...
7d ago
AZN
AstraZeneca Strengthens China Rare-Disease Position With New Real-World PNH Study Update
AstraZeneca ($AZN) announced an update on their ongoing clinical study. AstraZeneca Updates Real-World Study on Rare Blood Disorder...
7d ago
AZN
Bristol-Myers Squibb to Launch Phase 3 Trial for Schizophrenia Drug KarXT in Adolescents
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb has commenced...
8d ago
BMY
Nurix Therapeutics Advances Study for NX-5948 in CLL and SLL Patients
Nurix Therapeutics, Inc. ($NRIX) announced an update on their ongoing clinical study. Study Overview: Nurix Therapeutics, Inc. (NRIX)...
8d ago
NRIX
Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb (BMY) has...
8d ago
BMY
Eli Lilly’s Phase 2 Study on Imlunestrant: A Potential Game-Changer in Breast Cancer Treatment
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
8d ago
LLY
Globus Medical Advances Clinical Study on REFLECT™ Scoliosis System
Globus Medical ($GMED) announced an update on their ongoing clinical study. Globus Medical (GMED) is recruiting participants for...
8d ago
GMED
Iovance Biotherapeutics Advances Innovative Melanoma Treatment with Updated Study
Iovance Biotherapeutics ($IOVA) announced an update on their ongoing clinical study. Iovance Biotherapeutics has provided an update on...
8d ago
IOVA
SHOW MORE
You need to enable JavaScript to run this app.
